BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang Y, Wu G, Li Q, Zheng Y, Liu M, Zhou L, Chen Z, Wang Y, Guo Q, Ji R, Zhou Y. Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular Carcinoma. Front Mol Biosci 2021;8:690206. [PMID: 34262941 DOI: 10.3389/fmolb.2021.690206] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Chen J, Chen X, Li T, Wang L, Lin G. Identification of chromatin organization-related gene signature for hepatocellular carcinoma prognosis and predicting immunotherapy response. Int Immunopharmacol 2022;109:108866. [PMID: 35691273 DOI: 10.1016/j.intimp.2022.108866] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wu G, Yang Y, Zhu Y, Li Y, Zhai Z, An L, Liu M, Zheng Y, Wang Y, Zhou Y, Guo Q. Comprehensive Analysis to Identify the Epithelial-Mesenchymal Transition-Related Immune Signatures as a Prognostic and Therapeutic Biomarkers in Hepatocellular Carcinoma. Front Surg 2021;8:742443. [PMID: 34722623 DOI: 10.3389/fsurg.2021.742443] [Reference Citation Analysis]
3 Lv W, Yao Q, Wang F. A Novel Hypoxic-Angiogenesis-Immune-Related Gene Model for Prognostic and Therapeutic Effect Prediction in Hepatocellular Carcinoma Patients. Disease Markers 2022;2022:1-27. [DOI: 10.1155/2022/9428660] [Reference Citation Analysis]
4 Liu B, Liu Z, Feng C, Tu C. A Necroptosis-Related lncRNA Signature Predicts Prognosis and Indicates the Immune Microenvironment in Soft Tissue Sarcomas. Front Genet 2022;13:899545. [DOI: 10.3389/fgene.2022.899545] [Reference Citation Analysis]
5 Fu XW, Song CQ. Identification and Validation of Pyroptosis-Related Gene Signature to Predict Prognosis and Reveal Immune Infiltration in Hepatocellular Carcinoma. Front Cell Dev Biol 2021;9:748039. [PMID: 34820376 DOI: 10.3389/fcell.2021.748039] [Reference Citation Analysis]
6 Liu L, Zhu H, Wang P, Wu S. Construction of a Six-Gene Prognostic Risk Model Related to Hypoxia and Angiogenesis for Cervical Cancer. Front Genet 2022;13:923263. [DOI: 10.3389/fgene.2022.923263] [Reference Citation Analysis]
7 Liu H, Yan B, Chen Y, Pang J, Li Y, Zhang Z, Li C, Qin T, B S. Identification of Potential Prognostic Biomarkers Associated with Monocyte Infiltration in Lung Squamous Cell Carcinoma. BioMed Research International 2022;2022:1-19. [DOI: 10.1155/2022/6860510] [Reference Citation Analysis]
8 Yue H, Hu Z, Hu R, Guo Z, Zheng Y, Wang Y, Zhou Y. ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism. Front Oncol 2022;12:918778. [DOI: 10.3389/fonc.2022.918778] [Reference Citation Analysis]
9 Chen J, Gao G, Li L, Ding J, Chen X, Lei J, Long H, Wu L, Long X, He L, Shen Y, Yang J, Lu Y, Sun Y. Pan-Cancer Study of SHC-Adaptor Protein 1 (SHC1) as a Diagnostic, Prognostic and Immunological Biomarker in Human Cancer. Front Genet 2022;13:817118. [DOI: 10.3389/fgene.2022.817118] [Reference Citation Analysis]